Sylvie Picard

2.1k total citations
61 papers, 1.5k citations indexed

About

Sylvie Picard is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sylvie Picard has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sylvie Picard's work include Diabetes Management and Research (13 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (7 papers). Sylvie Picard is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes Treatment and Management (9 papers) and Diabetes and associated disorders (7 papers). Sylvie Picard collaborates with scholars based in France, Canada and United States. Sylvie Picard's co-authors include Joseph L. Witztum, Christian F. Deschepper, Wulf Palinski, Seppo Ylä‐Herttuala, Daniel Steinberg, Madhu B. Anand‐Srivastava, Timothy L. Reudelhuber, Srinivasan Parthasarathy, Joachim Fruebis and Christelle Thibault-Carpentier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Sylvie Picard

57 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Picard France 20 396 389 368 326 241 61 1.5k
Denise McDonald United Kingdom 17 291 0.7× 379 1.0× 181 0.5× 300 0.9× 147 0.6× 34 1.5k
María Carolina Góngora United States 15 397 1.0× 498 1.3× 155 0.4× 433 1.3× 193 0.8× 19 2.0k
Elizabeth A. Kirk United States 25 498 1.3× 732 1.9× 288 0.8× 247 0.8× 520 2.2× 35 2.5k
Kenya Sakamoto Japan 21 204 0.5× 390 1.0× 609 1.7× 434 1.3× 301 1.2× 41 1.8k
Yuliya Mikhed Germany 12 210 0.5× 526 1.4× 380 1.0× 364 1.1× 280 1.2× 18 1.5k
Antonio J. Cayatte United States 12 435 1.1× 369 0.9× 241 0.7× 650 2.0× 301 1.2× 17 1.8k
Kazuhiro Sonoda Japan 14 194 0.5× 784 2.0× 275 0.7× 183 0.6× 263 1.1× 17 1.7k
Hisako Matsui‐Hirai Japan 15 210 0.5× 260 0.7× 155 0.4× 237 0.7× 204 0.8× 18 1.0k
Modar Kassan United States 24 278 0.7× 651 1.7× 238 0.6× 319 1.0× 264 1.1× 60 1.8k
Shojiro Sawada Japan 25 266 0.7× 665 1.7× 513 1.4× 350 1.1× 681 2.8× 63 2.1k

Countries citing papers authored by Sylvie Picard

Since Specialization
Citations

This map shows the geographic impact of Sylvie Picard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Picard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Picard more than expected).

Fields of papers citing papers by Sylvie Picard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Picard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Picard. The network helps show where Sylvie Picard may publish in the future.

Co-authorship network of co-authors of Sylvie Picard

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Picard. A scholar is included among the top collaborators of Sylvie Picard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Picard. Sylvie Picard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Picard, Sylvie, Jean‐Pierre Riveline, Jean‐Baptiste Julla, et al.. (2025). Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study. Diabetes & Metabolism. 51(4). 101647–101647.
3.
Picard, Sylvie, et al.. (2025). Le CIRDIA, un nouveau concept d’organisation des soins pour le diabète de type 1 en France. Médecine des Maladies Métaboliques. 19(3). 235–241.
5.
Pépin, Jean‐Louis, Sébastien Bailly, J. Texereau, et al.. (2023). Prevalence of sleep apnoea in patients with type 1 diabetes and its association with comorbidities and diabetic complications: A French nationwide prospective study. Diabetes Obesity and Metabolism. 25(6). 1624–1631. 6 indexed citations
6.
Scailteux, Lucie‐Marie, Clémence Lacroix, Fabien Despas, et al.. (2020). Profils d’effets indésirables sous abiratérone et enzalutamide : analyse descriptive des données de la base nationale de pharmacovigilance. Therapies. 76(5). 455–465. 4 indexed citations
8.
Scott‐Boyer, Marie‐Pier, Nicolas Tremblay, Sophie Cardin, et al.. (2016). Association of a Network of Interferon-Stimulated Genes with a Locus Encoding a Negative Regulator of Non-conventional IKK Kinases and IFNB1. Cell Reports. 17(2). 425–435. 2 indexed citations
9.
Praktiknjo, Samantha D., Sylvie Picard, & Christian F. Deschepper. (2016). Comparisons of chromosome Y-substituted mouse strains reveal that the male-specific chromosome modulates the effects of androgens on cardiac functions. Biology of Sex Differences. 7(1). 61–61. 4 indexed citations
10.
Gras, Valérie, Joëlle Micallef, Sylvie Picard, et al.. (2016). The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database. British Journal of Clinical Pharmacology. 83(6). 1341–1349. 85 indexed citations
11.
Picard, Sylvie, Élisabeth Polard, Emmanuel Oger, & Éric Bellissant. (2014). Impact de la mise en place d’un réseau régional de pharmacovigilance sur la notification d’effets indésirables : bilan à 3 ans. Therapies. 70(3). 293–299. 2 indexed citations
12.
Billard, C., et al.. (2005). BREV, une batterie d'évaluation des fonctions cognitives : validation dans les troubles des apprentissages. Archives de Pédiatrie. 13(1). 23–31. 17 indexed citations
13.
Picard, Sylvie, et al.. (2003). Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts. Journal of Biological Chemistry. 278(48). 47694–47699. 75 indexed citations
14.
Farnier, Michel & Sylvie Picard. (2001). Diabetes: Statins, fibrates, or both?. Current Atherosclerosis Reports. 3(1). 19–28. 19 indexed citations
15.
Cao, Huibi, Anik Girard-Globa, André Sérusclat, et al.. (1998). Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus. Atherosclerosis. 138(2). 361–366. 40 indexed citations
16.
Touyz, Rhian M., Sylvie Picard, Ernesto L. Schiffrin, & Christian F. Deschepper. (1997). Cyclic GMP Inhibits a Pharmacologically Distinct Na+/H+ Exchanger Variant in Cultured Rat Astrocytes via an Extracellular Site of Action. Journal of Neurochemistry. 68(4). 1451–1461. 30 indexed citations
17.
Deschepper, Christian F. & Sylvie Picard. (1994). Effects of C‐Type Natriuretic Peptide on Rat Astrocytes: Regional Differences and Characterization of Receptors. Journal of Neurochemistry. 62(5). 1974–1982. 34 indexed citations
18.
Anand‐Srivastava, Madhu B., Sylvie Picard, & Christelle Thibault-Carpentier. (1991). Altered Expression of Inhibitory Guanine Nucleotide Regulatory Proteins (Gi ) in Spontaneously Hypertensive Rats. American Journal of Hypertension. 4(10 Pt 1). 840–843. 55 indexed citations
19.
Chambrier, C., Sylvie Picard, Hubert Vidal, et al.. (1990). Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism. Metabolism. 39(9). 976–984. 16 indexed citations
20.
Anand‐Srivastava, Madhu B., Marc Cantin, M. Ballak, & Sylvie Picard. (1989). Desensitization of the stimulatory A2 adenosine receptor-adenylate cyclase system in vascular smooth muscle cells from rat aorta. Molecular and Cellular Endocrinology. 62(2). 273–279. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026